San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Once someone decides they need an abortion, they will go to great lengths to get one because they know it is the right ...

A research team at the USF College of Nursing is creating a new anti-cancer telemedicine program for older adults.

The move is the latest voluntary effort by U.S. food manufacturers to heed calls from the Trump administration to remove ...

Wegovy (semaglutide) will no longer be available through Hims & Hers Health, as Novo Nordisk has ended its short-lived partnership.

Novo Nordisk teamed up with the company in a bid to broaden access to Wegovy and get patients back onto the US Food and Drug Administration (FDA)-approved product.

Recent restructuring efforts at the Food and Drug Administration may have been well-intentioned, but they risk undermining the very innovation and domestic capacity the president seeks to promote.

This spring, the Trump administration renewed calls to bring drug manufacturing and production back to American shores, reigniting debate about what it will take to move onshoring from a lofty ...